Key facts
- This page summarizes Amit Sachdev's Form 4 filing for VERTEX PHARMACEUTICALS INC / MA (VRTX).
- 12 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 23 Feb 2026, 16:21.
Amit Sachdev - 19 Feb 2026 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)
- Reporting relationship
- EVP Chief Patient & Ext Af Off
- Issuer ticker
- VRTX
- Reported as of
- 19 Feb 2026
- Net transaction value
- -$19,133,829
- SEC form
- 4
- Accepted by SEC
- 23 Feb 2026, 16:21:44 UTC
- Prior SEC filing
- 19 Feb 2026
- Next SEC filing
- 26 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christiana Stevenson, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Amit Sachdev filed Form 4 for VERTEX PHARMACEUTICALS INC / MA (VRTX) on 23 Feb 2026.
Change
- Previous filing in this sequence was filed on 19 Feb 2026.
- Current net transaction value: -$19,133,829.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001406338
Primary reporting owner
Sachdev Amit
- Relationship
- EVP Chief Patient & Ext Af Off
- Address
- C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON
- Signature
- /s/ Christiana Stevenson, Attorney-in-Fact
- Signature date
- 23 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VRTX
transaction
Common Stock
Options Exercise
- Transaction value
- $3,652,628
- Shares
- +23,479
- Change %
- +34%
- Price
- $155.57
- Shares after
- 92,521
- Date
- 19 Feb 2026
- Ownership
- Direct
VRTX
transaction
Common Stock
Options Exercise
- Transaction value
- $4,693,126
- Shares
- +25,026
- Change %
- +27%
- Price
- $187.53
- Shares after
- 117,547
- Date
- 19 Feb 2026
- Ownership
- Direct
VRTX
transaction
Common Stock
Sale
- Transaction value
- $426,797
- Shares
- -920
- Change %
- -0.78%
- Price
- $463.91
- Shares after
- 116,627
- Date
- 19 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F2, F3
VRTX
transaction
Common Stock
Sale
- Transaction value
- $1,269,586
- Shares
- -2,730
- Change %
- -2.3%
- Price
- $465.05
- Shares after
- 113,897
- Date
- 19 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F3, F4
VRTX
transaction
Common Stock
Sale
- Transaction value
- $860,798
- Shares
- -1,848
- Change %
- -1.6%
- Price
- $465.80
- Shares after
- 112,049
- Date
- 19 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F3, F5
VRTX
transaction
Common Stock
Sale
- Transaction value
- $4,800,518
- Shares
- -10,263
- Change %
- -9.2%
- Price
- $467.75
- Shares after
- 101,786
- Date
- 19 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F3, F6
VRTX
transaction
Common Stock
Sale
- Transaction value
- $9,213,023
- Shares
- -19,662
- Change %
- -19%
- Price
- $468.57
- Shares after
- 82,124
- Date
- 19 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F3, F7
VRTX
transaction
Common Stock
Sale
- Transaction value
- $3,400,446
- Shares
- -7,241
- Change %
- -8.8%
- Price
- $469.61
- Shares after
- 74,883
- Date
- 19 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F3, F8
VRTX
transaction
Common Stock
Sale
- Transaction value
- $5,510,964
- Shares
- -11,712
- Change %
- -16%
- Price
- $470.54
- Shares after
- 63,171
- Date
- 19 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F3, F9
VRTX
transaction
Common Stock
Sale
- Transaction value
- $1,997,449
- Shares
- -4,237
- Change %
- -6.7%
- Price
- $471.43
- Shares after
- 58,934
- Date
- 19 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F3, F10
VRTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 882
- Date
- 19 Feb 2026
- Ownership
- 401(k)
VRTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 9,301
- Date
- 19 Feb 2026
- Ownership
- Held in Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VRTX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -23,479
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 19 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 23,479
- Exercise price
- $155.57
- Footnotes
- F11
VRTX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -25,026
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 19 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,026
- Exercise price
- $187.53
- Footnotes
- F11
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 11 footnotes
Footnote F1
Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 11/18/2025.
Footnote F2
Open market sales reported on this line occurred at a weighted average price of $463.91 (range $463.44 to $464.28).
Footnote F3
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Footnote F4
Open market sales reported on this line occurred at a weighted average price of $465.05 (range $464.48 to $465.46).
Footnote F5
Open market sales reported on this line occurred at a weighted average price of $465.80 (range $465.54 to $466.49).
Footnote F6
Open market sales reported on this line occurred at a weighted average price of $467.75 (range $467.09 to $468.05).
Footnote F7
Open market sales reported on this line occurred at a weighted average price of $468.57 (range $468.10 to $469.09).
Footnote F8
Open market sales reported on this line occurred at a weighted average price of $469.61 (range $469.10 to $470.05).
Footnote F9
Open market sales reported on this line occurred at a weighted average price of $470.54 (range $470.10 to $471.08).
Footnote F10
Open market sales reported on this line occurred at a weighted average price of $471.43 (range $471.10 to $472.03).
Footnote F11
Fully vested.